AACR 2026 | BlissBio to Present 3 Posters at the 2026 AACR Annual Meeting
Source:
|
Author:BlissBio
|
Published time: 2026-04-20
|
21 Views
|
🔊 Click to read aloud
❚❚
▶
|
Share:
HANGZHOU, China, April 20, 2026 - BlissBio announces today that 3 posters on preclinical studies of novel ADCs and masked TCE will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026. The conference is held from April 17 to 22, 2026, at the San Diego Convention Center in San Diego, California, USA.
HANGZHOU, China, April 20, 2026 - BlissBio announces today that 3 posters on preclinical studies of novel ADCs and masked TCE will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026. The conference is held from April 17 to 22, 2026, at the San Diego Convention Center in San Diego, California, USA.
Title: A DR5-targeting ADC Exhibits Superior Anti-tumor Activity and Potentially Better Therapeutic Window
Poster No.& Poster Board No.: 2637 / 13
Session Time: 09:00 AM - 12:00 PM on April 20, 2026
Title: A Novel Tumor-Microenvironment-Responsive Pro-TCE Therapy Minimizes Cytokine Release for Safer Solid Tumor Treatment
Abstract No. & Poster Board No.: LB259 / 8
Session Time: 09:00 AM - 12:00 PM on April 21, 2026
Title:Tri-specific ADC Platform Offers Potential Therapeutic Advantage over Bi-specific ADC
Poster No. & Poster Board No.: 6939 / 20
Session Time: 09:00 AM - 12:00 PM on April 22, 2026
Bliss Biopharmaceutical Co., Ltd.
TEL: +86-0571-86808367
E-mail: office@blissbiopharma.com
